Cargando…
The CYP19A1 (TTTA)n Repeat Polymorphism May Affect the Prostate Cancer Risk: Evidence from a Meta-Analysis
Abnormal aromatase (CYP19A1) expression may participate in prostate cancer (PCa) carcinogenesis. However, the results of studies on the CYP19A1 gene polymorphisms and PCa are conflicting. This meta-analysis aimed to systematically evaluate the associations between the CYP19A1 Arg264Cys polymorphism...
Autores principales: | Guo, Lei, Liu, Yanan, Liu, Lijun, Shao, Shixiu, Cao, Yanwei, Guo, Jiaming, Niu, Haitao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161905/ https://www.ncbi.nlm.nih.gov/pubmed/34036824 http://dx.doi.org/10.1177/15579883211017033 |
Ejemplares similares
-
Polymorphism in the Androgen Biosynthesis Gene (CYP17), a Risk for Prostate Cancer: A Meta-Analysis
por: Effah, Clement Yaw, et al.
Publicado: (2020) -
Global, Regional, and National Incidence and Year Lived with Disability for Benign Prostatic Hyperplasia from 1990 to 2019
por: Xu, Xiao-Feng, et al.
Publicado: (2021) -
Deterioration in Sleep Quality Affects Cognitive Depression in
Prostate Cancer Patients
por: Sharpley, Christopher F., et al.
Publicado: (2021) -
Body Mass Index and Risk of Prostate Volume, International Prostate Symptom Score, Maximum Urinary Flow Rate, and Post-Void Residual in Benign Prostatic Hyperplasia Patients
por: Li, Bing-Hui, et al.
Publicado: (2019) -
Prostatic Artery Embolization for Benign Prostatic Hyperplasia
Treatment: A Russian Multicenter Study in More Than 1,000 Treated
Patients
por: Kamalov, Armais, et al.
Publicado: (2020)